(Q57786833)

6

0 references

author name string

Marco Chilosi

1

0 references

Maurizio Pea

2

0 references

Guido Martignoni

3

0 references

Matteo Brunelli

4

0 references

Franco Bonetti

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.189

7

0 references

publication date

5 December 2008

0 references

published in

Modern Pathology

0 references

volume

22

0 references

issue

2

0 references

page(s)

161-166

0 references

exact match

0 references

cites work

Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

PEComas: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Cellular heterogeneity in lymphangiomyomatosis of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Markers of Cell Proliferation and Expression of Melanosomal Antigen in Lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Identification and characterization of the tuberous sclerosis gene on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Tuberous sclerosis: from tubers to mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

mTOR is activated in the majority of malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Cathepsin K in melanoma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Pivotal role of cathepsin K in lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Transbronchial Biopsy in Lymphangiomyomatosis of the Lung HMB45 for Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Diagnostic invasive procedures in diffuse infiltrative lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

Bone mineral density in lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

21 January 2018

Lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

7 January 2021

Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

7 January 2021

Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

7 January 2021

Perivascular epithelioid cell

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

7 January 2021

Sirolimus treatment for pulmonary lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

7 January 2021

The collagenolytic activity of cathepsin K is unique among mammalian proteinases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.189

7 January 2021